Eucrates Biomedical Acquisition - Warrants (23/10/2027) Overview

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Operating Income

Operating Income for EUCRW.

Quarterly Operating Income

$-263192.00

↓ 46.65% YoY

As of Dec 31, 2022

Annual Operating Income (TTM)

$-698578.00

↓ 30.35% YoY

Trailing 12 months ending Dec 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin